Methanol extract of dried exudate of Commiphora mukul prevents bone resorption in ovariectomized rats

References

• Agrinier N, Cournot M, Dallongeville J, Arveiler D, Ducimetière P, Ruidavets JB, Ferrières J. (2010). Menopause and modifiable coronary heart disease risk factors: A population based study. Maturitas, 65, 237–243.
   PubMed Web of Science ®Google Scholar
• Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. (1974). Enzymatic determination of total serum cholesterol. Clin Chem, 20, 470–475.
   PubMed Web of Science ®Google Scholar
• Barrett-Connor E. (1996). The menopause, hormone replacement, and cardiovascular disease: The epidemiologic evidence. Maturitas, 23, 227–234.
   PubMed Web of Science ®Google Scholar
• Botto N, Maffei S, Manfredi S, Colombo MG, Mazzone AM, Andreassi MG. (2011). Prothrombotic mutations, family history and the risk of thrombosis in postmenopausal women: Implications for hormone replacement therapy. Climacteric, 14, 25–30.
   PubMed Web of Science ®Google Scholar
• Burtis CA, Ashwood ER. (1986). Tietz Text Book of Clinical Biochemisry, 2nd ed., vol. 833. Saunders: London, pp. 1890–1891.
   Google Scholar
• Canderelli R, Leccesse LA, Miller NL, Unruh Davidson J. (2007). Benefits of hormone replacement therapy in postmenopausal women. J Am Acad Nurse Pract, 19, 635–641.
   PubMedGoogle Scholar
• Canfell K, Banks E, Moa AM, Beral V. (2008). Decrease in breast cancer incidence following a rapid fall in use of hormone replacement therapy in Australia. Med J Aust, 188, 641–644.
   PubMed Web of Science ®Google Scholar
• Chander R, Khanna AK, Pratap R. (2002). The antioxidant activity of guggulsterone: The active principle from gugglulipid of Commiphora Mukul. J Med Aromat Plant Sci, 24, 370–374.
   Google Scholar
• Cooper C, Campion G, Melton LJ III. (1992). Hip fractures in the elderly: a world-wide projection. Osteoporosis Int, 2, 285–289.
   PubMed Web of Science ®Google Scholar
• Croucher PI. (2005). Osteoblastic metastases. In: Jasmin C, Coleman RE, Coia LR, Capanna R, Saillant G. (Eds.), Textbook of Bone Metastases. England: John Wiley and Sons Ltd., pp. 42–44.
   Google Scholar
• Eastell R, Baumann M, Wieczorek L. (2001). Bone Markers: Biochemical and Clinical Perspectives. London: Martin Dunitz Ltd.,
   Google Scholar
• Epstein S. (2006). Update of current therapeutic options for the treatment of postmenopausal osteoporosis. Clin Ther, 28, 151–173.
   PubMed Web of Science ®Google Scholar
• Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, Christiansen C, Delmas PD, Zanchetta JR, Stakkestad J, Glüer CC, Krueger K, Cohen FJ, Eckert S, Ensrud KE, Avioli LV, Lips P, Cummings SR. (1999). Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA, 282, 637–645.
   PubMed Web of Science ®Google Scholar
• Frost HM. (1992). The role of changes in mechanical usage set points in the pathogenesis of osteoporosis. J Bone Miner Res, 7, 253–261.
   PubMed Web of Science ®Google Scholar
• Garrett IR, Boyce BF, Oreffo RO, Bonewald L, Poser J, Mundy GR. (1990). Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo. J Clin Invest, 85, 632–639.
   PubMed Web of Science ®Google Scholar
• Halleen JM, Alatalo SL, Janckila AJ, Woitge HW, Seibel MJ, Väänänen HK. (2001). Serum tartrate-resistant acid phosphatase 5b is a specific and sensitive marker of bone resorption. Clin Chem, 47, 597–600.
   PubMed Web of Science ®Google Scholar
• Heaney RP, Recker RR, Saville PD. (1977). Calcium balance and calcium requirements in middle-aged women. Am J Clin Nutr, 30, 1603–1611.
   PubMed Web of Science ®Google Scholar
• Ichikawa H, Aggarwal BB. (2006). Guggulsterone inhibits osteoclastogenesis induced by receptor activator of nuclear factor-κB ligand and by tumor cells by suppressing nuclear factor-κB activation. Clin Cancer Res, 12, 662–668.
   PubMed Web of Science ®Google Scholar
• Jacobsen BK, Nilssen S, Heuch I, Kvåle G. (1997). Does age at natural menopause affect mortality from ischemic heart disease? J Clin Epidemiol, 50, 475–479.
   PubMed Web of Science ®Google Scholar
• Khanna D, Sethi G, Ahn KS, Pandey MK, Kunnumakkara AB, Sung B, Aggarwal A, Aggarwal BB. (2007). Natural products as a gold mine for arthritis treatment. Curr Opin Pharmacol, 7, 344–351.
   PubMed Web of Science ®Google Scholar
• Kimura I, Yoshikawa M, Kobayashi S, Sugihara Y, Suzuki M, Oominami H, Murakami T, Matsuda H, Doiphode VV. (2001). New triterpenes, myrrhanol A and myrrhanone A, from guggul-gum resins, and their potent anti-inflammatory effect on adjuvant-induced air-pouch granuloma of mice. Bioorg Med Chem Lett, 11, 985–989.
   PubMed Web of Science ®Google Scholar
• Lean JM, Davies JT, Fuller K, Jagger CJ, Kirstein B, Partington GA, Urry ZL, Chambers TJ. (2003). A crucial role for thiol antioxidants in estrogen-deficiency bone loss. J Clin Invest, 112, 915–923.
   PubMed Web of Science ®Google Scholar
• Mishra S. (2007). Commentary on Bhaisajya Ratnavali. Ed. 1. Varanasi: Choukhamba, Surbharti Prakashan.
   Google Scholar
• Novack DV. (2007). Estrogen and bone: Osteoclasts take center stage. Cell Metab, 6, 254–256.
   PubMed Web of Science ®Google Scholar
• Oge A, Bayraktar F, Sevin G, Uyulgan B, Yilmaz C, Kabalak T. (2002). A comparative study of raloxifen and estrogen on bone strength and cholesterol levels in ovariectomized rats. British Endocrine Societies Joint Meeting 2002, Endocrine Abstracts, Endocrine Abstracts Harrogate, UK, p. 3 P10.
   Google Scholar
• Palmer JR, Rosenberg L, Shapiro S. (1992). Reproductive factors and risk of myocardial infarction. Am J Epidemiol, 136, 408–416.
   PubMed Web of Science ®Google Scholar
• Peng Z, Tuukkanen J, Zhang H, Jämsä T, Väänänen HK. (1994). The mechanical strength of bone in different rat models of experimental osteoporosis. Bone, 15, 523–532.
   PubMed Web of Science ®Google Scholar
• Penolazzi L, Lampronti I, Borgatti M, Khan MT, Zennaro M, Piva R, Gambari R. (2008). Induction of apoptosis of human primary osteoclasts treated with extracts from the medicinal plant Emblica officinalis. BMC Complement Altern Med, 8, 59.
   PubMed Web of Science ®Google Scholar
• Riggs BL, Khosla S, Melton LJ 3rd. (2002). Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev, 23, 279–302.
   PubMed Web of Science ®Google Scholar
• Riis B, Thomsen K, Christiansen C. (1987). Does calcium supplementation prevent postmenopausal bone loss? A double-blind, controlled clinical study. N Engl J Med, 316, 173–177.
   PubMed Web of Science ®Google Scholar
• Satyavati GV. (1988). Gum guggul (Commiphora mukul)–the success story of an ancient insight leading to a modern discovery. Indian J Med Res, 87, 327–335.
   PubMed Web of Science ®Google Scholar
• Sharma JN, Sharma JN. (1977). Comparison of the anti-inflammatory activity of Commiphora mukul (an indigenous drug) with those of phenylbutazone and ibuprofen in experimental arthritis induced by mycobacterial adjuvant. Arzneimittelforschung, 27, 1455–1457.
   PubMed Web of Science ®Google Scholar
• Shirwaikar A, Khan S, Kamariya YH, Patel BD, Gajera FP. (2010). Medicinal plants for the management of post menopausal osteoporosis: A review. The Open Bone Journal, 2, 1–13.
   Google Scholar
• Somerman MJ, McCauley LK. (2006). Bisphosphonates: Sacrificing the jaw to save the skeleton. Bonekey Osteovision, 3, 12–8.
   Google Scholar
• Sudarshana V, Deepa. (2008). Antioxidant studies on the ethanolic extract of Commiphora spp. Afr J Biotechnol, 8, 1630–1636.
   Google Scholar
• Sushruta. (1907). Dosha-Dhatu-Mala-Kshaya-Vriddhi-Vijnaniya-madhyayam. In Bhishagratna KKL, ed. An English Translation of The Sushrutha Samhita Vol I Suthrasthanam. Culcutta: Wilkins Press, 120–139.
   Google Scholar
• Szejnfeld VL. (2000). Manifestacoes clinicas. Osteoporose: Diagnostico e tratamento. Sarvier: Sao Paulo.
   Google Scholar
• Tracy RE. (1966). Sex difference in coronary disease: Two opposing views. J Chronic Dis, 19, 1245–1251.
   PubMedGoogle Scholar
• Tunstall-Pedoe H. (1998). Myth and paradox of coronary risk and the menopause. Lancet, 351, 1425–1427.
   PubMed Web of Science ®Google Scholar
• Urizar NL, Liverman AB, Dodds DT, Silva FV, Ordentlich P, Yan Y, Gonzalez FJ, Heyman RA, Mangelsdorf DJ, Moore DD. (2002). A natural product that lowers cholesterol as an antagonist ligand for FXR. Science, 296, 1703–1706.
   PubMed Web of Science ®Google Scholar
• Urizar NL, Moore DD. (2003). GUGULIPID: A natural cholesterol-lowering agent. Annu Rev Nutr, 23, 303–313.
   PubMed Web of Science ®Google Scholar
• van der Schouw YT, van der Graaf Y, Steyerberg EW, Eijkemans JC, Banga JD. (1996). Age at menopause as a risk factor for cardiovascular mortality. Lancet, 347, 714–718.
   PubMed Web of Science ®Google Scholar
• Varley H. (1980). Practical Biochemistry, Vol. 1. London: William Heinemann Medical Books Ltd, p. 913.
   Google Scholar
• Wang X, Greilberger J, Ledinski G, Kager G, Paigen B, Jürgens G. (2004). The hypolipidemic natural product Commiphora mukul and its component guggulsterone inhibit oxidative modification of LDL. Atherosclerosis, 172, 239–246.
   PubMed Web of Science ®Google Scholar
• Wuttke W, Jarry H, Becker T, Schultens A, Christoffel V, Gorkow C, Seidlová-Wuttke D. (2008). Phytoestrogens: Endocrine disrupters or replacement for hormone replacement therapy? Maturitas, 61, 159–170.
   PubMed Web of Science ®Google Scholar